About 68.5 million Americans are currently enrolled in some type of Medicare plan, with about 90% of enrollees being over age 65, according to the Centers for Medicare & Medicaid Services.

Rinvoq, a Janus kinase (JAK) inhibitor, can be covered by Medicare drug plans, but coverage and costs vary by specific plan.

Medicare offers various exceptions to beneficiaries, including tiering, formulary, and continuing employment. Generally, Medicare has set rules and regulations. However, there are certain times and ...

The Medicare Part D program provides vital healthcare services through prescription drug coverage through approved private insurers. However, there are penalties for late enrolment ...

As more adults are looking for help to face overactive bladder (OAB), they wonder if their plan will cover the essensials for ...

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

Prescription volume for specialty medications, not price hikes, largely seems to be the main factor in the ongoing huge ...

Civil monetary penalties against payers for improperly delaying or denying coverage, hitting members with higher cost sharing ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

As an injectable drug, Reclast is typically covered by Original Medicare (parts A and B) instead of Part D, which covers oral prescription drugs and other self-administered drugs.

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

The Centers for Medicare & Medicaid Services’ annual pay rate proposal for outpatient and ambulatory surgical centers (ASCs) ...